
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hereditas</journal-id><journal-id journal-id-type="iso-abbrev">Hereditas</journal-id><journal-title-group><journal-title>Hereditas</journal-title></journal-title-group><issn pub-type="ppub">0018-0661</issn><issn pub-type="epub">1601-5223</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">33407909</article-id><article-id pub-id-type="pmc">7788922</article-id><article-id pub-id-type="publisher-id">170</article-id><article-id pub-id-type="doi">10.1186/s41065-020-00170-w</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Report</subject></subj-group></article-categories><title-group><article-title>A novel intron mutation in <italic>FBN-1</italic> gene identified in a pregnant woman with Marfan syndrome</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wu</surname><given-names>Yuduo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sun</surname><given-names>Hairui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>He</surname><given-names>Yihua</given-names></name><address><email>yihuaheecho@163.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Hongjia</given-names></name><address><email>zhanghongjia722@ccmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Department of Cardiac Surgery, Beijing Anzhen Hospital, </institution><institution>Capital Medical University, </institution></institution-wrap>No.2, Anzhen Road, Chaoyang District, Beijing, 100029 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.419897.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 313X</institution-id><institution>Key Laboratory of Medical Engineering for Cardiovascular Disease, </institution><institution>Ministry of Education, </institution></institution-wrap>Beijing, China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Beijing Key Laboratory of Maternal-Fetal Medicine and Fetal Heart Disease, Beijing Anzhen Hospital, </institution><institution>Capital Medical University, </institution></institution-wrap>Beijing, China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Ultrasound Department of Beijing Anzhen Hospital, </institution><institution>Capital Medical University, </institution></institution-wrap>No.2, Anzhen Road, Chaoyang District, Beijing, 100029 China </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>6</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>158</volume><elocation-id>6</elocation-id><history><date date-type="received"><day>6</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Marfan syndrome (MFS) is one of the most common hereditary connective tissue diseases, with great individual heterogeneity. We reported a Chinese pregnancy with Clinical diagnosis of MFS, performed whole-exome sequencing, and screened for the genetic abnormality. We also conducted an in vitro mini-gene splicing assay to demonstrate the predicted harmful effects of an intronic variant of <italic>FBN-1</italic>. Exome sequencing identified a novel intronic variant (c.6497-13&#x02009;T&#x0003e;A) in intron 53 of the <italic>FBN-1</italic> gene (NM_000138.4). It&#x02019;s predicted to insert 11&#x02009;bp of intron 53 into the mature mRNA. The mini-gene splicing experiment demonstrated that c.6497-13&#x02009;T&#x0003e;A could result in 11&#x02009;bp retention in intron 53 to exon 54 (c.6496_6497ins gtttcttgcag) and the use of an alternative donor causing the frameshift p.Asp2166Glyfs*23. According to the results, the pregnant woman chose to continue the pregnancy and gave birth to a healthy baby. This study expands the genetic mutation spectrum of MFS patients and indicates the importance of intron sequencing.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s41065-020-00170-w.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Marfan syndrome</kwd><kwd><italic>FBN-1</italic> gene</kwd><kwd>Splicing mutation</kwd><kwd>Mini gene</kwd><kwd>Sequencing</kwd></kwd-group><funding-group><award-group><funding-source><institution>the National Key R&#x00026;D Program of China</institution></funding-source><award-id>2018YFC1002300</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002888</institution-id><institution>Beijing Municipal Commission of Education</institution></institution-wrap></funding-source><award-id>DFL20180602</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Marfan syndrome (MFS) is an autosomal dominant connective tissue disease with an incidence of 2&#x02013;3/10000 without any ethnic, geographic, or professional orientation [<xref ref-type="bibr" rid="CR1">1</xref>]. The condition caused by mutations in the human fibrillin-1 (<italic>FBN-1</italic>) gene [<xref ref-type="bibr" rid="CR2">2</xref>]. More than 3000 <italic>FBN-1</italic> site mutations have been reported. The mutation spectrum is composed of nonsense, missense, frameshift, and exon deletion, etc. [<xref ref-type="bibr" rid="CR3">3</xref>] Among them, about 90% of MFS patients&#x02019; mutation sequence information limited to the coding region and specific splice sites. However, about 10% of patients still cannot identify the genetic cause of the disease [<xref ref-type="bibr" rid="CR1">1</xref>]. Part of the reason may be that advances in sequencing have not significantly affected the clinical interpretation of uncertain significance variants, such as intron variants that may affect splicing [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. This study, reports a pregnant woman with a clinical diagnosis of MFS, who carried a novel intron mutation (NM_000138.4:c.6497-13&#x02009;T&#x0003e;A). Through the in vitro characterization of the effect of this mutation on mRNA, we determined that it was a pathogenic mutation and used it for the patient&#x02019;s family management, and successfully gave birth to a normal baby. The report is as follows.</p></sec><sec id="Sec2"><title>Case presentation</title><sec id="Sec3"><title>Patient information</title><p id="Par6">Proband female: 33&#x02009;years old, height 183&#x02009;cm, weight 60&#x02009;kg, the patient admitted to the cardiac surgery department of our hospital because of a sudden aortic dissection, and the physical examination found: slender limbs, positive wrist signs, thoracic deformity, high myopia, as shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. Ultrasound examination revealed: widening of the aortic root, mitral valve prolapse, clinical suspected MFS, surgical treatment, no genetic testing. Last year, the patient was pregnant and had another outpatient consultation. Family status: The family has three generations, five people, and one patient (the proband herself), as shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. The proband&#x02019;s parents and younger brother have no clinical symptoms of MFS, and both parents have no relatives with relevant symptoms.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Arachnodactyly of the proband (<bold>a</bold> and <bold>b</bold>); positive wrist (<bold>c</bold>); characteristic face with dolichocephaly, malar hypoplasia, enophthalmos, myopia more than 3 diopters (<bold>d</bold>)</p></caption><graphic xlink:href="41065_2020_170_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Family diagram of the proband, I-1, I-2: parents of the proband; II-1: proband; II-2: younger brother of the proband; III-1: son of the proband</p></caption><graphic xlink:href="41065_2020_170_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec4"><title>Molecular findings</title><p id="Par7">A trio (proband and her parents) whole-exome sequencing was performed using methods described previously [<xref ref-type="bibr" rid="CR6">6</xref>]. Whole-Exome sequencing identified a novel variant, c.6497-13&#x02009;T&#x0003e;A, in intron 53 of the <italic>FBN-1</italic> gene (NM_000138.4). Subsequent Sanger sequencing confirmed that the mutation was heterozygous in the pregnant woman (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) and wild-type in her parents, younger brother, and fetus.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Sanger sequence diagram of the proband, the red arrow points to the mutation site. Polymerase chain reaction (PCR) amplication was performed using forward primer (caactcctgtgagctgttgc) and reverse primer (acgttgtccacagtgagtcc). The obtained sequence was compared with the <italic>FBN-1</italic> reference gene (NM_000138.4) to identify mutations</p></caption><graphic xlink:href="41065_2020_170_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Results of the mini-gene splicing assay. <bold>a</bold> Schematic diagram of mini-gene construction and the c.6497-13&#x02009;T&#x0003e;A variant related abnormal splicing. The asterisk indicates the location of the c.6497-13&#x02009;T&#x0003e;A variant. <bold>b</bold> Gel electrophoresis of RT-PCR products: the band of the mutant was bigger than the wild-type. <bold>c</bold> Mini-gene product sequencing results: <bold>a</bold> The wild-type mini-gene (FBN1-wt) formed normal mRNA composed of exon54; <bold>b</bold> The mutant mini-gene (FBN1-mut) caused a splicing abnormality, resulting in the retention of the 11&#x02009;bp in intron 53</p></caption><graphic xlink:href="41065_2020_170_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec5"><title>In silico splicing analysis</title><p id="Par8">Computational predictions conducted using HSF (<ext-link ext-link-type="uri" xlink:href="http://www.umd.be/HSF3/HSF.html">http://www.umd.be/HSF3/HSF.html</ext-link>) revealed that the intronic c.6497-13&#x02009;T&#x0003e;A variant might influence the splicing process by differentially affecting canonical versus cryptic splice site utilization. The newly detected variant predicted to insert 11&#x02009;bp of intron 53 into the mature mRNA (Fig. <xref rid="Fig4" ref-type="fig">4</xref>-a). This variant should give rise to a frameshift and a premature termination codon (p.Asp2166Glyfs*23).</p></sec><sec id="Sec6"><title>Results of the mini-gene splicing assay</title><p id="Par9">To prove that the c.6497-13&#x02009;T&#x0003e;A variant caused the 11&#x02009;bp insertion, we then conducted the mini-gene splicing experiment using RNA from blood lymphocytes as described previously [<xref ref-type="bibr" rid="CR7">7</xref>]. The mini-gene splicing products were analyzed by PCR amplification with plasmid-specific primers and visualized with polyacrylamide gel electrophoresis. The electrophoresis results of wild-type and c.6497-13&#x02009;T&#x0003e;A transfections indicated that the mutant band was bigger than the wild-type, and the migration became slower (Fig. <xref rid="Fig4" ref-type="fig">4</xref>-b). The amplicons confirmed by Sanger sequencing showed that the cDNA fragment obtained from the c.6497-13&#x02009;T&#x0003e;A plasmid contained an additional 11&#x02009;bp in intron 53 to exon 54 (c.6496_6497ins gtttcttgcag) (Fig. <xref rid="Fig4" ref-type="fig">4</xref>-c). This result is consistent with the in silico analysis result.</p></sec><sec id="Sec7"><title>Screening of other genes associated with thoracic aortic aneurysm and dissection</title><p id="Par10">Besides finding the <italic>FBN-1</italic> mutation presented above, we also analyzed variants in genes associated with thoracic aortic aneurysm and dissection (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). No pathogenic/likely pathogenic variants were identified in these genes.</p></sec></sec><sec id="Sec8"><title>Discussion</title><p id="Par11">This study describes a pregnancy with Clinically diagnosed MFS that carried a novel intronic variant in the <italic>FBN-1</italic> gene. We added this novel variant to the <italic>FBN-1</italic> mutational repertoire and demonstrated this variant&#x02019;s effect at the mRNA level by in vitro Mini-gene splicing assay. Furthermore, Based on the results of genetic tests, pregnancy decisions are guided.</p><p id="Par12">This novel intronic variant in the <italic>FBN-1</italic> gene (c.6497-13&#x02009;T&#x0003e;A) has previously not been reported as pathogenic or benign and has not observed in the general population (gnomAD: <ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org">https://gnomad.broadinstitute.org</ext-link>). It showed a deleterious effect by multiple in silico algorithms. Furthermore, in vitro experiment of mini-gene splicing assay verified that the variant alters splicing, leading to a frameshift and a premature termination codon. It is a loss-of-function variant and expected to result in either an abnormal truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Following the revised Ghent nosology for the MFS, the c.6497-13&#x02009;T&#x0003e;A variant was pathogenic. In this work, we highlighted the importance of including extended intronic regions in analysizing WES (whole-exome sequencing, WES) results during variant prioritization and post-analytical phase for clinical purposes. This work also points out the need to introduce functional investigations to verify further the pathogenicity of intronic variants with a potential pathogenic effect.</p><p id="Par13">Through this study, we also found that the diagnosis of MFS through genetic testing has limitations. Despite advances in genetic testing technology, about 10% of patients still cannot be diagnosed through genetics. According to our case and some previous scattered case reports, it&#x02019;s suggeste that part of the reason is the variation of introns or other non-coding regions [<xref ref-type="bibr" rid="CR8">8</xref>]. On the other hand, it is necessary to consider the differentiation from other hereditary macrovascular diseases, such as: Loeys-Dietz Syndrom, Ehlers-Danlos Syndrom, etc. [<xref ref-type="bibr" rid="CR9">9</xref>] We found no relevant mutations in the case.</p><p id="Par14">For MFS patients with atypical clinical phenotypes, genetic testing can not only diagnose the disease but also distinguish it from other genetic macrovascular diseases with similar phenotypes. Through large-scale testing within the family, it is also possible to find patients with gene mutations without clinical phenotypes and help them prevent adverse aortic events in advance. At the same time, it can also provide fertility guidance for women of childbearing age. Like the pregnant women in this study, she performed amniocentesis in the second trimester. The genetic test results showed negative, and the pregnancy continued, giving birth to a healthy baby.</p><p id="Par15">Because both parents are not the carrier for the mutation, the proband&#x02019;s mutation should be a de novo mutation in the family. Although the proband gave birth to a healthy baby, if this patient becomes pregnant again in the future, the probability of MFS in the second child is still 50% [<xref ref-type="bibr" rid="CR1">1</xref>]. Therefore, we recommended that this part of patients undergo amniotic fluid puncture during the second trimester of pregnancy and check the karyotype.</p><p id="Par16">In conclusion, this study enlarges the mutation spectrum of <italic>FBN-1</italic> and points out the importance of intronic sequence analysis and the need for integrated functional studies in <italic>FBN-1</italic> diagnosis. The literature on <italic>FBN-1</italic> intronic variants affecting non-typical splice sites is currently limited to single reports [<xref ref-type="bibr" rid="CR10">10</xref>]. Therefore, the large sample size and large cohort study need to carry out. To further reveal the significance of non-coding region (intron) variation to MFS.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Information</title><sec id="Sec9"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41065_2020_170_MOESM1_ESM.xlsx"><caption><p><bold>Additional file 1: Supplementary Table&#x000a0;1.</bold> Genes associated with thoracic aortic aneurysm and dissection.</p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>MFS</term><def><p id="Par2">Marfan syndrome</p></def></def-item><def-item><term>WES</term><def><p id="Par3">whole exome sequencing</p></def></def-item><def-item><term>PCR</term><def><p id="Par4">Polymerase chain reaction</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Yuduo Wu and Hairui Sun are joint first authors.</p></fn></fn-group><ack><p>This study complied with the Declaration of Helsinki and approved by the Ethics Committee of Anzhen Hospital, Capital Medical University. The proband and all family members signed an informed consent form. The personal information of the proband and all family members is strictly confidential. We thank our laboratory for helping for the biochemical evaluation of the patient and the families for their kind availability in sharing the scientific community&#x02019;s findings.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Yuduo Wu was mainly responsible for the article&#x02019;s writing and case collection, Hairui Sun was mainly responsible for the gene sequencing part of the article; Yihua He and Hongjia Zhang were mainly responsible for the overall thinking and fund support of the article. The author(s) read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the National Key R&#x00026;D Program of China (2018YFC1002300) and Beijing Municipal Administration of Hospitals&#x02019;Ascent Plan (DFL20180602).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Availably.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par17">All authors declare no conflict of interest concerning this work.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verstraeten</surname><given-names>A</given-names></name><name><surname>Alaerts</surname><given-names>M</given-names></name><name><surname>Van Laer</surname><given-names>L</given-names></name><name><surname>Loeys</surname><given-names>B</given-names></name></person-group><article-title>Marfan syndrome and related disorders: 25 years of gene discovery</article-title><source>Hum Mutat</source><year>2016</year><volume>37</volume><fpage>524</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1002/humu.22977</pub-id><pub-id pub-id-type="pmid">26919284</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Godfrey</surname><given-names>M</given-names></name><name><surname>Vitale</surname><given-names>E</given-names></name><name><surname>Hori</surname><given-names>H</given-names></name><name><surname>Mattei</surname><given-names>M</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name><name><surname>Tsipouras</surname><given-names>P</given-names></name><name><surname>Ramirez</surname><given-names>F</given-names></name><name><surname>Hollister</surname><given-names>D</given-names></name></person-group><article-title>Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes</article-title><source>Nature</source><year>1991</year><volume>352</volume><fpage>330</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1038/352330a0</pub-id><pub-id pub-id-type="pmid">1852206</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Lan</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Increased frequency of FBN1 frameshift and nonsense mutations in Marfan syndrome patients with aortic dissection</article-title><source>Mol Genet Genomic Med</source><year>2019</year><volume>8</volume><fpage>e1041</fpage><pub-id pub-id-type="pmid">31830381</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrado</surname><given-names>M</given-names></name><name><surname>Maneiro</surname><given-names>E</given-names></name><name><surname>Trujillo-Quintero</surname><given-names>J</given-names></name><name><surname>Evangelista</surname><given-names>A</given-names></name><name><surname>Mikhailov</surname><given-names>A</given-names></name><name><surname>Monserrat</surname><given-names>LJB</given-names></name></person-group><article-title>A Novel Heterozygous Intronic Mutation in the Gene Contributes to RNA Missplicing Events in the Marfan Syndrome</article-title><source>Biomed Res Int</source><year>2018</year><volume>2018</volume><fpage>3536495</fpage><pub-id pub-id-type="doi">10.1155/2018/3536495</pub-id><pub-id pub-id-type="pmid">30003093</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayhan</surname><given-names>G</given-names></name><name><surname>Ergun</surname><given-names>MA</given-names></name><name><surname>Ergun</surname><given-names>SG</given-names></name><name><surname>Kula</surname><given-names>S</given-names></name><name><surname>Percin</surname><given-names>FE</given-names></name></person-group><article-title>Identification of three novel FBN1 mutations and their phenotypic relationship of Marfan syndrome</article-title><source>Genet Test Mol Biomarkers</source><year>2018</year><volume>22</volume><fpage>474</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1089/gtmb.2017.0286</pub-id><pub-id pub-id-type="pmid">30048161</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Yi</surname><given-names>T</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wan</surname><given-names>P</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>Y</given-names></name></person-group><article-title>Contribution of single-gene defects to congenital cardiac left-sided lesions in the prenatal setting</article-title><source>Ultrasound Obstet Gynecol</source><year>2020</year><volume>56</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1002/uog.21883</pub-id><pub-id pub-id-type="pmid">31633846</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanyun Wang</surname><given-names>YS</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name></person-group><article-title>Functional Characterization of Argininosuccinate Lyase Gene Variants by Mini-Gene Splicing Assay</article-title><source>Front Genet</source><year>2019</year><volume>10</volume><fpage>436</fpage><pub-id pub-id-type="doi">10.3389/fgene.2019.00436</pub-id><pub-id pub-id-type="pmid">31156699</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname><given-names>C</given-names></name><name><surname>Morlino</surname><given-names>S</given-names></name><name><surname>Micale</surname><given-names>L</given-names></name><name><surname>Ferraris</surname><given-names>A</given-names></name><name><surname>Grammatico</surname><given-names>P</given-names></name><name><surname>Castori</surname><given-names>M</given-names></name></person-group><article-title>Characterization of two novel Intronic variants affecting splicing in FBN1-related disorders</article-title><source>Genes</source><year>2019</year><volume>10</volume><fpage>442</fpage><pub-id pub-id-type="doi">10.3390/genes10060442</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheulot</surname><given-names>P</given-names></name><name><surname>Saucedo</surname><given-names>M</given-names></name><name><surname>Bouvier-Colle</surname><given-names>MH</given-names></name><name><surname>Deneux Tharaux</surname><given-names>C</given-names></name><name><surname>Kayem</surname><given-names>G</given-names></name></person-group><article-title>Mortalit&#x000e9; maternelle chez les patientes atteintes de syndromes de Marfan ou d&#x02019;Ehlers-Danlos vasculaire en France, 2001&#x02013;2012</article-title><source>Gyn&#x000e9;col Obst&#x000e9;t Fertil S&#x000e9;nol</source><year>2019</year><volume>47</volume><fpage>30</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.gofs.2018.11.003</pub-id><pub-id pub-id-type="pmid">30497941</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wypasek</surname><given-names>E</given-names></name><name><surname>Potaczek</surname><given-names>D</given-names></name><name><surname>Hydzik</surname><given-names>M</given-names></name><name><surname>Stapor</surname><given-names>R</given-names></name><name><surname>Raczkowska-Muraszko</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><name><surname>Maugeri</surname><given-names>A</given-names></name><name><surname>Undas</surname><given-names>AJC</given-names></name></person-group><article-title>Detection and a functional characterization of the novel FBN1 intronic mutation underlying Marfan syndrome: case presentation</article-title><source>Clin Chem Lab Med</source><year>2018</year><volume>56</volume><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1515/cclm-2017-0042</pub-id><pub-id pub-id-type="pmid">29220879</pub-id></element-citation></ref></ref-list></back></article>